UNIPHARMA ApS: Financial statements 2019
CVR: 78881917
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK -5,000 and a net result of DKK -5,000 compared with DKK -10,140 the year before. Equity in the 2019 report amounted to DKK 66,735. The solvency ratio was 37%.
- Revenue
- DKK -5,000
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -5,000
- Equity
- DKK 66,735
- Total Assets
- DKK 180,490
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
| 2018 | -10 t. | -10 t. | -10 t. | 72 t. | - |
| 2017 | -9 t. | -9 t. | -9 t. | 73 t. | - |
| 2016 | - | -11 t. | -11 t. | 82 t. | - |
| 2015 | - | -6 t. | -6 t. | 93 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
UNIPHARMA ApS has published its annual report for 2018. Revenue came to DKK -10,140, and the net result was DKK -10,140.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.